Global deterioration of cardiovascular mechanics by carfilzomib treatment is associated with proteasome activity in patients with relapsed multiple myeloma.
Event: ESC Congress 2021 - The Digital Experience
Topic: Cardiotoxicity of Drugs and Other Therapies
Session: Chronic heart failure e-posters
